BioSpace News Archive

Pattern Computer®, Inc. announced at the Bio International Conference in San Diego that it is filing provisional patent applications with the United States Patent Office which covers 14 insilico discoveries in the form of potentially synergistic drug combinations for metastatic castrate resistant prostate cancer.

Management of specialty cancer diagnostics company Precipio, Inc. is requesting that shareholders instruct their brokers to vote their shares immediately no later than 11pm Eastern Time.

NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will host a virtual KOL (Key Opinion Leader) event Tuesday June 18, 2024 at 9:00-10:30AM EDT / 3:00-4:30PM CEST.

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the publication of a scientific article in Nature Communications, unveiling a non-viral gene therapy approach for sickle cell disease.

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that David Stamler, M.D., Chief Executive Officer will present a company overview at the MST Access ‘Hidden Gems in Life Sciences’ webinar on Thursday, 13 June 2024 in Australia / Wednesday, 12 June 2024 in the United States.

Innovent Biologics, Inc. announced that the U.S. Food and Drug Administration has granted Fast Track Designation to its TOPO1i anti-CLDN18.2 ADC, for the treatment of advanced unresectable or metastatic pancreatic ductal adenocarcinoma that has relapsed and/or is refractory to one prior line of therapy.

GenomesDAO, a pioneering biotech company focused on the secure, private, and auditable monetization of genomic data, announced the successful completion of a new investment round led by Pantera Capital and Modular Capital.